You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CESAMET Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cesamet, and what generic alternatives are available?

Cesamet is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in CESAMET is nabilone. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the nabilone profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CESAMET?
  • What are the global sales for CESAMET?
  • What is Average Wholesale Price for CESAMET?
Summary for CESAMET
Drug patent expirations by year for CESAMET
Drug Prices for CESAMET

See drug prices for CESAMET

Recent Clinical Trials for CESAMET

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Samuel Lunenfeld Research Institute, Mount Sinai HospitalN/A
New York State Psychiatric InstitutePhase 2
National Institute of Mental Health (NIMH)Phase 1/Phase 2

See all CESAMET clinical trials

Pharmacology for CESAMET
Drug ClassCannabinoid

US Patents and Regulatory Information for CESAMET

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch CESAMET nabilone CAPSULE;ORAL 018677-001 Dec 26, 1985 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CESAMET

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch CESAMET nabilone CAPSULE;ORAL 018677-001 Dec 26, 1985 ⤷  Sign Up ⤷  Sign Up
Bausch CESAMET nabilone CAPSULE;ORAL 018677-001 Dec 26, 1985 ⤷  Sign Up ⤷  Sign Up
Bausch CESAMET nabilone CAPSULE;ORAL 018677-001 Dec 26, 1985 ⤷  Sign Up ⤷  Sign Up
Bausch CESAMET nabilone CAPSULE;ORAL 018677-001 Dec 26, 1985 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for CESAMET

See the table below for patents covering CESAMET around the world.

Country Patent Number Title Estimated Expiration
Israel 45662 1-HYDROXY-3-ALKYL-HEXAHYDRO-DIBENZO(B,D)PYRAN-9-ONES AND PSYCHOTROPIC OR SEDATIVE DRUGS CONTAINING THEM ⤷  Sign Up
Sweden 7413832 ⤷  Sign Up
German Democratic Republic 116229 ⤷  Sign Up
Netherlands 180979 ⤷  Sign Up
Philippines 12320 DIBENZO(B,D)PYRANONE DISPERSIONS ⤷  Sign Up
South Africa 7405870 ⤷  Sign Up
Poland 94965 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.